Cargando…
New Treatment Option for Autoimmune Enteropathy: A Rare Case of Intractable Diarrhea Treated with Vedolizumab
Autoimmune enteropathy is an uncommon cause of chronic diarrhea rarely seen in adults. The disease is secondary to an autoimmune process in the gut that leads to villous blunting and subsequent watery diarrhea, abdominal pain, and severe weight loss. The disease has only been described in 37 adults...
Autores principales: | Robbins, Gordon, Tracht, Jessica, Davis, Drew, Iskandar, Heba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Gastroenterology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358579/ https://www.ncbi.nlm.nih.gov/pubmed/30775395 http://dx.doi.org/10.14309/crj.2018.92 |
Ejemplares similares
-
Autoimmune Enteropathy: A Rare Cause of Chronic Diarrhea in an Adult Patient
por: Carvalho, Ana C., et al.
Publicado: (2023) -
Vedolizumab Therapy in Refractory Enteropathy Associated With CVID
por: Johnson, Dane, et al.
Publicado: (2021) -
Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea
por: Zama, Daniele, et al.
Publicado: (2014) -
Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumab
por: Yeh, Jennifer E., et al.
Publicado: (2017) -
Using Adalimumab to Treat Autoimmune Enteropathy
por: Trivedi, Hirsh D., et al.
Publicado: (2019)